Insert prefilled glass syringe into autoinjector and close device (combination-product assembly)
As Pfizer's portfolio shifts toward self-administered biologics, prefilled glass syringes (PFS) must be assembled into autoinjector or pen housings: seating the syringe (typically referenced at the shoulder or flange), engaging the plunger/spring subassembly, and snapping the housing closed. The PFS shoulder is formed over a tungsten pin and is inherently variable in geometry, and needle placement and stoppering offsets compound that variability, so the syringe presents an imperfectly known target each cycle. The task sits at final device assembly, downstream of fill-finish and inspection. It is hard for a robot because the glass is fragile, insertion forces must be controlled to avoid cracking or mis-seating, and the snap closure must be confirmed as fully engaged. Misassembly produces a non-functional combination product carrying expensive drug. We identified this through our own research; we have not confirmed the specifics with the customer directly. This page is our researched read — a starting point for that conversation.
What the task is
RESEARCHED · our reconstructionAs Pfizer's portfolio shifts toward self-administered biologics, prefilled glass syringes (PFS) must be assembled into autoinjector or pen housings: seating the syringe (typically referenced at the shoulder or flange), engaging the plunger/spring subassembly, and snapping the housing closed. The PFS shoulder is formed over a tungsten pin and is inherently variable in geometry, and needle placement and stoppering offsets compound that variability, so the syringe presents an imperfectly known target each cycle. The task sits at final device assembly, downstream of fill-finish and inspection. It is hard for a robot because the glass is fragile, insertion forces must be controlled to avoid cracking or mis-seating, and the snap closure must be confirmed as fully engaged. Misassembly produces a non-functional combination product carrying expensive drug.
Is this the actual task and sequence? What are the real tolerances, cycle rate, and reject criteria, and which steps are today's manual bottleneck? Answering these is what turns this from a researched signal into a validated use case.